189 related articles for article (PubMed ID: 34865860)
1. Better late than never: Brachytherapy is more important than timing in treatment of locally advanced cervical cancer.
Korenaga TK; Yoshida EJ; Pierson W; Chang J; Ziogas A; Swanson ML; Chapman JS; Sinha S; Chen LM
Gynecol Oncol; 2022 Feb; 164(2):348-356. PubMed ID: 34865860
[TBL] [Abstract][Full Text] [Related]
2. Disparities in standard of care treatment and associated survival decrement in patients with locally advanced cervical cancer.
Robin TP; Amini A; Schefter TE; Behbakht K; Fisher CM
Gynecol Oncol; 2016 Nov; 143(2):319-325. PubMed ID: 27640961
[TBL] [Abstract][Full Text] [Related]
3. Racial disparities in brachytherapy administration and survival in women with locally advanced cervical cancer.
Alimena S; Yang DD; Melamed A; Mahal BA; Worley MJ; Feldman S; Elias KM; Orio PF; Lee LJ; King M
Gynecol Oncol; 2019 Sep; 154(3):595-601. PubMed ID: 31292103
[TBL] [Abstract][Full Text] [Related]
4. Identifying disparities in brachytherapy delivery for locally advanced cervical cancer.
Eakin A; Wairiri L; Stadtlander W; Bruegl A; Emerson J; Williamson C; Kahn J
Brachytherapy; 2023; 22(4):461-467. PubMed ID: 37015846
[TBL] [Abstract][Full Text] [Related]
5. Disparities Among Cervical Cancer Patients Receiving Brachytherapy.
Bruce SF; Joshi TV; Chervoneva I; Yi M; Chatterjee-Paer S; Burton ER; Edelson MI; Sorosky JI; Shahin MS
Obstet Gynecol; 2019 Sep; 134(3):559-569. PubMed ID: 31403593
[TBL] [Abstract][Full Text] [Related]
6. Clinical outcomes following conventional external beam radiotherapy boost in Japanese patients with cervical cancer who are ineligible for intracavitary brachytherapy.
Ito K; Shimizuguchi T; Karasawa K
Jpn J Clin Oncol; 2019 Mar; 49(3):270-275. PubMed ID: 30576504
[TBL] [Abstract][Full Text] [Related]
7. Impact of Brachytherapy Boost and Dose-escalated External Beam Radiotherapy in Margin Positive Cervical Cancer Treated With Chemotherapy and Radiation.
Ager BJ; Torgeson A; Francis SR; Burt LM; Gaffney DK; Cannon DM
Am J Clin Oncol; 2020 Jan; 43(1):35-42. PubMed ID: 31764024
[TBL] [Abstract][Full Text] [Related]
8. Association of Hospital Volume With Racial and Ethnic Disparities in Locally Advanced Cervical Cancer Treatment.
Uppal S; Chapman C; Spencer RJ; Jolly S; Maturen K; Rauh-Hain JA; delCarmen MG; Rice LW
Obstet Gynecol; 2017 Feb; 129(2):295-304. PubMed ID: 28079775
[TBL] [Abstract][Full Text] [Related]
9. Chemoradiation in cervical cancer with cisplatin and high-dose rate brachytherapy combined with external beam radiotherapy. Results of a phase-II study.
Strauss HG; Kuhnt T; Laban C; Puschmann D; Pigorsch S; Dunst J; Koelbl H; Haensgen G
Strahlenther Onkol; 2002 Jul; 178(7):378-85. PubMed ID: 12163992
[TBL] [Abstract][Full Text] [Related]
10. Patterns of care with brachytherapy for cervical cancer.
Bagshaw HP; Pappas LM; Kepka DL; Tward JD; Gaffney DK
Int J Gynecol Cancer; 2014 Nov; 24(9):1659-64. PubMed ID: 25251463
[TBL] [Abstract][Full Text] [Related]
11. A feasibility study of topotecan with standard-dose cisplatin and concurrent primary radiation therapy in locally advanced cervical cancer.
Gatcliffe TA; Tewari KS; Shah A; Brewster WR; Burger RA; Kuo JV; Monk BJ
Gynecol Oncol; 2009 Jan; 112(1):85-9. PubMed ID: 18977518
[TBL] [Abstract][Full Text] [Related]
12. External Beam Radiation Therapy and Brachytherapy for Cervical Cancer: The Experience of the National Centre for Radiotherapy in Accra, Ghana.
Vulpe H; Asamoah FA; Maganti M; Vanderpuye V; Fyles A; Yarney J
Int J Radiat Oncol Biol Phys; 2018 Apr; 100(5):1246-1253. PubMed ID: 29395628
[TBL] [Abstract][Full Text] [Related]
13. Impact of marital status on receipt of brachytherapy and survival outcomes in locally advanced cervical cancer.
Huynh-Le MP; Klapheke A; Cress R; Mell LK; Yashar CM; Einck JP; Mundt AJ; Mayadev JS
Brachytherapy; 2019; 18(5):612-619. PubMed ID: 31153760
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of sociodemographic and baseline patient characteristic differences in cervical cancer patients treated with either external beam or brachytherapy boost.
Lu DJ; Atkins KM; Small W; Kamrava M
Brachytherapy; 2022; 21(1):22-28. PubMed ID: 34895839
[TBL] [Abstract][Full Text] [Related]
15. Underutilization of brachytherapy and disparities in survival for patients with cervical cancer in California.
Mayadev J; Klapheke A; Yashar C; Hsu IC; Kamrava M; Mundt AJ; Mell LK; Einck J; Benedict S; Valicenti R; Cress R
Gynecol Oncol; 2018 Jul; 150(1):73-78. PubMed ID: 29709291
[TBL] [Abstract][Full Text] [Related]
16. Prognostic factors in definitive radiotherapy of uterine cervical cancer.
Yalman D; Aras AB; Ozkök S; Duransoy A; Celik OK; Ozsaran Z; Haydaroğlu A
Eur J Gynaecol Oncol; 2003; 24(3-4):309-14. PubMed ID: 12807246
[TBL] [Abstract][Full Text] [Related]
17. Delays in definitive cervical cancer treatment: An analysis of disparities and overall survival impact.
Ramey SJ; Asher D; Kwon D; Ahmed AA; Wolfson AH; Yechieli R; Portelance L
Gynecol Oncol; 2018 Apr; 149(1):53-62. PubMed ID: 29605051
[TBL] [Abstract][Full Text] [Related]
18. Combined low-dose-rate brachytherapy and external beam radiation for cervical cancer: experience over ten years.
Han I; Orton C; Shamsa F; Hart K; Strowbridge A; Deppe G; Porter A; Chuba PJ
Radiat Oncol Investig; 1999; 7(5):289-96. PubMed ID: 10580898
[TBL] [Abstract][Full Text] [Related]
19. Outcomes of high-dose-rate interstitial brachytherapy in the treatment of locally advanced cervical cancer: long-term results.
Pinn-Bingham M; Puthawala AA; Syed AM; Sharma A; Disaia P; Berman M; Tewari KS; Randall-Whitis L; Mahmood U; Ramsinghani N; Kuo J; Chen WP; McLaren CE
Int J Radiat Oncol Biol Phys; 2013 Mar; 85(3):714-20. PubMed ID: 22763030
[TBL] [Abstract][Full Text] [Related]
20. Improved survival of patients with cervical cancer treated with image-guided brachytherapy compared with conventional brachytherapy.
Rijkmans EC; Nout RA; Rutten IH; Ketelaars M; Neelis KJ; Laman MS; Coen VL; Gaarenstroom KN; Kroep JR; Creutzberg CL
Gynecol Oncol; 2014 Nov; 135(2):231-8. PubMed ID: 25172763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]